DUBLIN, December 06, 2021--(BUSINESS WIRE)--The "Global Diagnostics Imaging Market (2021-2027) By Product, Application, End Users and Geography, Impact of Covid-19, Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.
Diagnostics Imaging includes variety of non-invasive methods for scanning and examining the body for diagnostics and treatment purposes. The imaging techniques are also used for post-treatment check-ups.
The Global Diagnostics Imaging Market is estimated to be USD 29.6 Bn in 2021 and is expected to reach USD 43.93 Bn in 2027, growing at a CAGR of 6.8%.
Growth of the market is attributed to the increasing demand for early diagnosis and increasing scope of clinical applications, rapidly increasing geriatric population, increasing investment and funding by PPP.
The market is hampered due to a high cost of equipment, increasing regulatory burden and limitations associated with the standalone systems. Emerging countries in the APAC and Africa are creating opportunities for market players. Furthermore, adoption of AI, Analytics and Blockchain in the medical technology is also creating various growth opportunities in the market.
Oncology diagnostics imaging accounts for largest market share due to the increasing prevalence of the diseases.
By products, MRI systems holds largest market share of Global Diagnostics Imaging Market. The growth of the segment is attributed to the high adoption of MRI systems and the need for early diagnostics.
North America is expected to have largest market share in the world and is expected to grow during the forecasted period. The market is expected to grow due to technological advances, higher affordability, increasing number of registered cases in the USA, Canada and Mexico.
The Asia Pacific region is expected to grow at highest CAGR owing to the improving healthcare systems, increasing investment in the region.
Rapidly growing geriatric population and the subsequent increase in the prevalence of associated diseases
Increasing demand for early diagnosis and increasing scope of clinical applications
Technological advancements in diagnostic imaging modalities
Increasing Investments, funds, and grants by Public-Private Organizations
High cost of equipment
Increasing regulatory burden and declining reimbursement
Limitations associated with standalone systems
Adoption of AI and Analytics in diagnostics Imaging
Use of Blockchain
Koninklijke Philips N.V.
FUJIFILM Holdings Corporation
Samsung Electronics Co., Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/dzk9yg
View source version on businesswire.com: https://www.businesswire.com/news/home/20211206005570/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900